The Company has further informed that 8,574,000 shares of the Company held by Late Mr. Mizanur Rahman Sinha, Sponsor Director and Managing Director of the company, have been transmitted to the BO account of his nominees, Ms. Tasneem Sinha, daughter of late Mr. Mizanur Rahman Sinha & Deputy Managing Director of the Company and Mr. Tanveer Sinha, son of late Mr. Mizanur Rahman Sinha & Director of the Company by way of nomination as per the news disseminated by DSE on June 3, 2026.

The Company has informed that Mr. Mizanur Rahman Sinha, Sponsor Director and Managing Director of the company, passed away on May 16, 2026. His holding of 8,574,000 shares of the Company will be transmitted to his nominees by way of nomination as follows: Ms. Tasneem Sinha, daughter of late Mr. Mizanur Rahman Sinha and Deputy Managing Director of the Company will receive 4,287,000 shares. Mr. Tanveer Sinha, son of late Mr. Mizanur Rahman Sinha and Director of the Company will receive 4,287,000 shares.

(Cont. News of ACMELAB): Net operating cash flow per share has been increased due to higher sales collections and lower procurement of materials. In addition, finance cost has been decreased while Inventory levels-including materials in transit has also been decreased. (end)

(Q3 Un-audited): EPS was Tk. 3.30 for January-March 2026 as against Tk. 2.81 for January-March 2025; EPS was Tk. 9.40 for July 2025-March 2026 as against Tk. 8.28 for July 2024-March 2025. NOCFPS was Tk. 19.78 for July 2025-March 2026 as against Tk. 7.76 (restated) for July 2024-March 2025. NAV per share was Tk. 132.27 as on March 31, 2026 and Tk. 126.37 as on June 30, 2025. (cont.)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.